Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

NorthX Biologics AB

Closing information (x1000 EUR)

Closing information 2022/12 2021/12 2020/12
Turnover 14,282 Less Arrow 13,548 Less Arrow 8,923
Financial expenses 71 Less Arrow 42 More Arrow 59
Earnings before taxes -1,055 Less Arrow -3,113 Less Arrow -4,113
EBITDA -390 Less Arrow -2,194 Less Arrow -3,478
Total assets 24,839 Less Arrow 21,653 Less Arrow 18,215
Current assets 12,404 Less Arrow 10,213 Less Arrow 7,986
Current liabilities 24,129 Less Arrow 21,444 Less Arrow 17,410
Equity capital 710 Less Arrow 210 More Arrow 805
- share capital 9 More Arrow 10 Equal arrow 10
Employees (average) 129 Less Arrow 124 Less Arrow 104

Financial ratios

Fiscal year 2022/12 2021/12 2020/12
Solvency 2.9% Less Arrow 1.0% More Arrow 4.4%
Turnover per employee 111 Less Arrow 109 Less Arrow 86
Profit as a percentage of turnover -7.4% Less Arrow -23.0% Less Arrow -46.1%
Return on assets (ROA) -4.0% Less Arrow -14.2% Less Arrow -22.3%
Current ratio 51.4% Less Arrow 47.6% Less Arrow 45.9%
Return on equity (ROE) -148.6% Less Arrow -1482.4% More Arrow -510.9%
Change turnover 1,832 More Arrow 4,790 Less Arrow 1,494
Change turnover % 15% More Arrow 55% Less Arrow 20%
Chg. No. of employees 5 More Arrow 20 More Arrow 24
Chg. No. of employees % 4% More Arrow 19% More Arrow 30%

Total value of public sale

Fiscal year 2022/12 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.